Release of β-Thromboglobulin from Human Platelets by Therapeutic Intensities of Ultrasound

Abstract
The effects of therapeutic intensities of ultrasound on human platelets in whole blood were investigated by monitoring the release of the platelet specific protein .beta.-thromboglobulin (.beta.-TG). More .beta.-TG was released as the intensity of the ultrasound increased and also as the driving frequency decreased from 3.0-0.75 mHz. Some .beta.-TG was released at spatially-averaged intensities as low as 0.6 W/cm2 at 0.75 mHz, a value significantly lower than that observed for the onset of aggregation of platelet rich plasma (obtained from the same volunteer) in the same exposure system. Liberation of .beta.-TG by ultrasound was diminished but not abolished with inhibitors which rendered the platelets functionally inert. .beta.-TG is apparently liberated in 2 ways: as a result of platelet disruption by cavitation, and subsequently by potent aggregating agents, liberated in parallel with .beta.-TG, inducing the physiological release reaction in adjacent platelets. The low therapeutic intensities and short exposure times (30 s or less) necessary to liberate .beta.-TG from normal human platelets in vitro, suggests that patients with abnormally sensitive platelets and/or hypercoagulable state could be at risk if subjected to high therapeutic intensities of ultrasound.
Keywords